- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Coelenterazine h |
| Catalog No. | RESK-0270 |
| Description | Coelenterazine h is a dehydroxylated derivative of native coelenterazine. It serves as a substrate for Renilla luciferase (Rluc) and as a cofactor of aequorin, producing a luminescence intensity more than 10-fold higher than that of native coelenterazine, making it well suited for reporter gene assays. It is also a cofactor of aequorin and can be used for the detection of calcium ion concentration in living cells, gene reporter assays, bioluminescence resonance energy transfer (BRET) studies, ELISA, high-throughput screening (HTS), and chemiluminescent detection of ROS levels in tissues or cells. |
| Intended Use | Reporter gene assays; detection of calcium ion concentration in living cells; BRET (bioluminescence resonance energy transfer) studies; ELISA; high-throughput screening (HTS); chemiluminescent detection of ROS levels in tissues or cells. For research use only. |
| Principle / Technology | Coelenterazine h is oxidized by Renilla luciferase (Rluc) or by aequorin (in the presence of Ca2+) to generate bioluminescence. As a dehydroxylated derivative of native coelenterazine, it yields a luminescence intensity more than 10-fold higher than native coelenterazine. |
| Detection Method | Bioluminescence / chemiluminescence detection using a luminometer or scintillation counter equipped with a bioluminescence detection module; small-animal in vivo imaging systems are also applicable. Fluorescence microscopy is not suitable. |
| Sample Type | Cultured cells, tissues, cell lysates, and living animals (in vivo imaging). |
| Performance Range / Specifications | English synonyms: 2-Deoxycoelenterazine; CLZN-h; h-CTZ CAS NO.: 50909-86-9 Formula: C26H21N3O2 Molecular weight: 407.5 g/mol Appearance: Yellow solid Solubility: Soluble in methanol and ethanol; insoluble in DMSO Purity (TLC): >99% Luminescence intensity: >10-fold higher than native coelenterazine |
| Reaction Conditions / Protocol | Stock solution (12 mM, ~5 mg/mL, 5x): Dissolve 1 mg of coelenterazine h powder directly in 197 uL of acidified methanol (100% methanol containing 20 uL/mL of 3 M or 6 M HCl). Working solution (in vitro, example): 10 uM for approximately 1x10^5 cells. The optimal working concentration should be determined empirically by titration according to the relevant literature. Detection timing: For in vitro assays, detect immediately after 10-15 min of cell incubation; for in vivo assays, detect within 10-15 min after injection. It is recommended to establish a luciferase kinetic curve in a preliminary experiment to determine the time of peak signal and the signal plateau. |
| Components / Formulation | Coelenterazine h (2-Deoxycoelenterazine), yellow solid powder. |
| Storage Conditions | Store the powder at -20 °C protected from light in a dry environment, preferably under inert gas and avoiding contact with air. For long-term storage, keep at -70 °C. |
| Shelf Life | 2 years when stored at -70 °C. |
| Package Specifications | 1x 500 ug 2x 500 ug 5 mg 2x 5 mg |
| Product Form | Yellow solid powder. |
| Quality Control | Purity >99% as determined by TLC. |
| Purity | >99% (TLC) |
| Molecular Weight | 407.5 g/mol |
| Source / Origin | Synthetic derivative of native coelenterazine (dehydroxylated form). |
| Shipping Conditions | Shipped with ice packs. |
| Expiration Date / Stability | Stable for 2 years when stored long-term at -70 °C protected from light and air. |
| Compatibility | Compatible with Renilla luciferase (Rluc)-based reporter systems and aequorin-based calcium detection; suitable for BRET, ELISA, and HTS formats. |
| Recommended Buffer System | Stock solutions are prepared in acidified methanol (100% methanol containing 20 uL/mL of 3 M or 6 M HCl); 1,2-propylene glycol and anhydrous ethanol may also be used as formulation solvents. |
| Application Notes / Precautions | Working concentrations cited from the literature are for reference only; perform a concentration gradient to determine the optimal concentration. The compound is readily oxidized; for in vivo imaging, a ready-to-use formulation is recommended because injection and anesthesia prolong the procedure, whereas in vitro detection is rapid and unaffected. Ensure that the detection instrument (e.g., a multifunctional microplate reader) is equipped with a bioluminescence detection module. Protect from light and air during handling and storage. |
For research use only, not for clinical use.
|
There is no product in your cart. |